Skip to content

Drug interactions

Bosentan + Temsirolimus

Severity: Moderate

Bosentan and Temsirolimus: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Temsirolimus and its active metabolite sirolimus are CYP3A4 substrates, and bosentan, a CYP3A4 inducer, may lower their exposure. This could reduce antitumour effect.

What this interaction means in plain words

Bosentan and Temsirolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Bosentan belongs to Miscellaneous; Temsirolimus belongs to Oncology.

Evidence level: Moderate

Why it happens

Bosentan induces CYP3A4, increasing metabolism of temsirolimus and sirolimus.

What to do

Monitor for reduced response and avoid combination if possible. If needed, consider temsirolimus dose adjustment per labeling for CYP3A4 inducers.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bosentan and Temsirolimus, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bosentan with Temsirolimus?

MediHelp rates the interaction as moderate. Bosentan and Temsirolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Temsirolimus and its active metabolite sirolimus are CYP3A4 substrates, and bosentan, a CYP3A4 inducer, may lower their exposure. This could reduce antitumour effect.

How serious is the interaction between Bosentan and Temsirolimus?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for reduced response and avoid combination if possible. If needed, consider temsirolimus dose adjustment per labeling for CYP3A4 inducers.

What other medicines interact with Temsirolimus?

MediHelp also lists interactions of Temsirolimus with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Measles mumps and rubella vaccine live. The full list is on the Temsirolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in